HTBX

Q: What is the price of Heat Biologics (HTBX) today?

The current price of Heat Biologics (HTBX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Heat Biologics (HTBX) pay dividends?

Heat Biologics (HTBX) did not pay dividends over the past year.

Heat Biologics Inc.

Price

$ -

return (12m)

0.00%

p/e

-1.79

p/bv

0.61

DIVIDEND YIELD

0.00%

HTBX price

Heat Biologics

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HTBX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals HTBX

review the fundamentals of Heat Biologics shares

P/E

-1.79

Sector: -3.78 Industry: -3.78

P/S (PSR)

77.65

Sector: -4.21 Industry: -4.21

P/BV

0.61

Sector: 1.92 Industry: 1.92

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-31.27%

Sector: -65.35% Industry: -65.35%

ROE

-33.76%

Sector: -65.97% Industry: -65.97%

ROIC

Sector: -2,922.25% Industry: -2,922.25%

NET MARGIN

-100.00%

Sector: -40.35% Industry: -40.35%

GROSS MARGIN

0.00%

Sector: 36.77% Industry: 36.77%

OPERATING MARGIN

-100.00%

Sector: -39.30% Industry: -39.30%

EV/EBITDA

-1.87

Sector: -3.87 Industry: -3.87

EV/EBIT

-1.82

Sector: -3.95 Industry: -3.95

PRICE-TO-ASSETS

0.56

Sector: 1.41 Industry: 1.41

BVPS

4.21

Sector: 1.88 Industry: 1.88

EPS

-1.42

Sector: -2.14 Industry: -2.14

EQUITY-TO-ASSETS RATIO

0.93

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.93

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

-6.44%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.37%

Sector: - Industry: -

Fundamentals HTBX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.50	6.87	25.92%	2.25%	$ 557.54 B	21.83%
PFE	19.79	1.64	8.29%	6.61%	$ 148.19 B	11.83%
ABBV	110.65	-60.83	-54.98%	2.97%	$ 402.20 B	5.79%
NVO	10.02	6.09	60.73%	4.34%	$ 191.12 B	37.14%
MRK	33.42	6.50	19.45%	2.75%	$ 298.59 B	13.59%
AZN	27.73	6.08	21.93%	1.72%	$ 288.04 B	17.19%
GILD	17.41	6.85	39.33%	2.47%	$ 160.42 B	30.99%
BMY	16.04	5.81	36.19%	4.37%	$ 116.72 B	15.01%
ZTS	12.68	10.37	81.75%	2.59%	$ 33.52 B	27.79%
REGN	14.94	2.10	14.08%	0.57%	$ 66.09 B	29.65%
HALO	24.20	38.43	158.82%	0.00%	$ 8.44 B	23.13%
AMGN	24.20	20.54	84.87%	2.80%	$ 188.77 B	20.96%
MCK	19.85	-113.34	-570.98%	0.41%	$ 94.53 B	1.18%
HRMY	12.82	2.05	16.00%	0.00%	$ 1.87 B	16.20%
VRTX	26.16	5.86	22.41%	0.00%	$ 113.49 B	35.51%
CAH	31.09	-18.09	-58.20%	0.99%	$ 48.34 B	0.62%
ADMA	11.37	4.82	42.37%	0.00%	$ 1.88 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HTBX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Heat Biologics

Heat Biologics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

2013

Time since IPO - 13 years

39

Employees

Heat Biologics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $64.10 Millions, with shareholders equity totaling $105.84 Millions.

The company employs approximately 39 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Heat Biologics Inc. reported $825.52 Thousand in revenue, generating net income of $-35.73 Millions.

Key financial metrics include a P/E ratio of -1.79, a price-to-book (P/B) ratio of 0.61, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HTBX.

Market cap

$ 64.10 Millions

Net worth

$ 105.84 Millions

$ 105,842,442.00

Assets

$ 114.27 Millions

$ 114,266,522.00

Total Shares Outstanding

25.14 Millions

25,137,000

Average Daily Trading Volume

$ 78.60 Thousand

$ 78,596.18

Sector

Health Care

Industry

Biotechnology

HTBX

HTBX revenue and profits

Financial Results HTBX

DRAG THE FRAME TO SEE MORE DATA

HTBX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 790.44 10,68% (12M)

P/E

19.85

0.41%

ROE

-570.98%

P/BV

-113.34

CAH - Cardinal Health

$ 216.30 42,85% (12M)

P/E

31.09

0.99%

ROE

-58.20%

P/BV

-18.09

JNJ - Johnson & Johnson

$ 238.49 57,46% (12M)

P/E

26.50

2.25%

ROE

25.92%

P/BV

6.87

MRK - Merck & Co.

$ 119.09 54,71% (12M)

P/E

33.42

2.75%

ROE

19.45%

P/BV

6.50

AZN - AstraZeneca

$ 178.96 21,40% (12M)

P/E

27.73

1.72%

ROE

21.93%

P/BV

6.08

ABBV - AbbVie

$ 224.95 21,20% (12M)

P/E

110.65

2.97%

ROE

-54.98%

P/BV

-60.83

NVO - Novo Nordisk

$ 42.81 --42,99% (12M)

P/E

10.02

4.34%

ROE

60.73%

P/BV

6.09

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 790.44 10,68% (12 M)

P/L

19.85

0.41%

ROE

-570.98%

P/VP

-113.34

CAH - Cardinal Health

$ 216.30 42,85% (12 M)

P/L

31.09

0.99%

ROE

-58.20%

P/VP

-18.09

JNJ - Johnson & Johnson

$ 238.49 57,46% (12 M)

P/L

26.50

2.25%

ROE

25.92%

P/VP

6.87

MRK - Merck & Co.

$ 119.09 54,71% (12 M)

P/L

33.42

2.75%

ROE

19.45%

P/VP

6.50

AZN - AstraZeneca

$ 178.96 21,40% (12 M)

P/L

27.73

1.72%

ROE

21.93%

P/VP

6.08

ABBV - AbbVie

$ 224.95 21,20% (12 M)

P/L

110.65

2.97%

ROE

-54.98%

P/VP

-60.83

NVO - Novo Nordisk

$ 42.81 --42,99% (12 M)

P/L

10.02

4.34%

ROE

60.73%

P/VP

6.09

Frequently Asked Questions

What is the price of Heat Biologics (HTBX) today?

The current price of Heat Biologics (HTBX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Heat Biologics (HTBX) pay dividends?

Heat Biologics (HTBX) did not pay dividends over the past year.

Is Heat Biologics (HTBX) a good investment?

Heat Biologics (HTBX) is currently trading at $ 0.00 with a P/E ratio of -1.79. This represents a -179% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Heat Biologics (HTBX) stock?

You can buy Heat Biologics (HTBX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol HTBX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Heat Biologics (HTBX) yield today?

Over the past month, Heat Biologics (HTBX) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Heat Biologics (HTBX) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

HTBX

Heat Biologics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment HTBX

review the fundamentals of Heat Biologics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Heat Biologics

Heat Biologics Inc.

United States

18 years

2013

39

PROFIT X PRICE HTBX

Financial Results HTBX

HTBX cash flow

Asset, Revenue and Profit Growth - HTBX

HTBX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions